These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29509533)

  • 1. New Minimally Invasive Endoscopic and Surgical Therapies for Gastroesophageal Reflux Disease (GERD).
    Nicolau AE; Lobonţiu A; Constantinoiu S
    Chirurgia (Bucur); 2018; 113(1):70-82. PubMed ID: 29509533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradigm shift in the management of gastroesophageal reflux disease.
    Richards WO; Houston HL; Torquati A; Khaitan L; Holzman MD; Sharp KW
    Ann Surg; 2003 May; 237(5):638-47; discussion 648-9. PubMed ID: 12724630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic Non-ablative Radiofrequency Treatment (Stretta) for Gastroesophageal Reflux Disease (GERD).
    Triadafilopoulos G
    Curr Gastroenterol Rep; 2024 Apr; 26(4):93-98. PubMed ID: 38393432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Approaches to Gastroesophageal Reflux Disease.
    Kethman W; Hawn M
    J Gastrointest Surg; 2017 Sep; 21(9):1544-1552. PubMed ID: 28623447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic anti-reflux mucosectomy (ARMS) and endoscopic anti-reflux ablation (ARMA) as a potential treatment for gastroesophageal reflux - preliminary report.
    Klimczak T; Strzelczyk J
    Pol Przegl Chir; 2023 Oct; 96(0):1-5. PubMed ID: 38348994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience.
    Repici A; Fumagalli U; Malesci A; Barbera R; Gambaro C; Rosati R
    J Gastrointest Surg; 2010 Jan; 14(1):1-6. PubMed ID: 19902310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transoral incisionless fundoplication for gastro-esophageal reflux disease: Techniques and outcomes.
    Testoni PA; Mazzoleni G; Testoni SG
    World J Gastrointest Pharmacol Ther; 2016 May; 7(2):179-89. PubMed ID: 27158533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stretta Radiofrequency Treatment for GERD: A Safe and Effective Modality.
    Franciosa M; Triadafilopoulos G; Mashimo H
    Gastroenterol Res Pract; 2013; 2013():783815. PubMed ID: 24078808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RefluxStop™ Therapy - a New Minimally Invasive Technology in Anti-reflux Surgery.
    Stephan D; Borbely Y; Schoppmann SF
    Surg Technol Int; 2022 Oct; 41():. PubMed ID: 36255718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of endoscopic radiofrequency Stretta therapy for patients with refractory gastroesophageal reflux disease.
    Kim SE
    Clin Endosc; 2024 Jan; 57(1):48-50. PubMed ID: 38204168
    [No Abstract]   [Full Text] [Related]  

  • 11. Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions.
    Mermelstein J; Chait Mermelstein A; Chait MM
    Clin Exp Gastroenterol; 2018; 11():119-134. PubMed ID: 29606884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the outcome of laparoscopic procedures for GERD.
    Rebecchi F; Allaix ME; Cinti L; Nestorović M; Morino M
    Updates Surg; 2018 Sep; 70(3):315-321. PubMed ID: 30027381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spotlight on the Linx™ Reflux Management System for the treatment of gastroesophageal reflux disease: evidence and research.
    Zadeh J; Andreoni A; Treitl D; Ben-David K
    Med Devices (Auckl); 2018; 11():291-300. PubMed ID: 30214323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of Evidence in Minimally Invasive Management of Gastroesophageal Reflux: Findings of a Scoping Review.
    Vaezi MF; Shaheen NJ; Muthusamy VR
    Gastroenterology; 2020 Oct; 159(4):1504-1525. PubMed ID: 32621903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transoral incisionless fundoplication with an ultrasonic surgical endostapler for the treatment of gastroesophageal reflux disease: 12-month outcomes.
    Testoni PA; Testoni S; Mazzoleni G; Pantaleo G; Cilona MB; Distefano G; Fanti L; Antonelli M; Passaretti S
    Endoscopy; 2020 Jun; 52(6):469-473. PubMed ID: 32187630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years.
    Testoni PA; Testoni S; Distefano G; Mazzoleni G; Fanti L; Passaretti S
    Endosc Int Open; 2019 May; 7(5):E647-E654. PubMed ID: 31058207
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of surgical payer costs and implication on the healthcare expenses between laparoscopic magnetic sphincter augmentation (MSA) and laparoscopic Nissen fundoplication (LNF) in a large healthcare system.
    Ayazi S; Zaidi AH; Zheng P; Chovanec K; Chowdhury N; Salvitti M; Newhams K; Levy J; Hoppo T; Jobe BA
    Surg Endosc; 2020 May; 34(5):2279-2286. PubMed ID: 31376004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Experience with Banded Anti-reflux Mucosectomy (ARMS) for GERD: Feasibility, Safety, and Technique (with Video).
    Hedberg HM; Kuchta K; Ujiki MB
    J Gastrointest Surg; 2019 Jun; 23(6):1274-1278. PubMed ID: 30734179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies.
    Asti E; Aiolfi A; Lazzari V; Sironi A; Porta M; Bonavina L
    Updates Surg; 2018 Sep; 70(3):323-330. PubMed ID: 30022361
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.